Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Arcadia Biosciences (RKDA) is now available.
Arcadia Biosciences, Inc. has elevated Thomas J. Schaefer to a Class I director position following Stanley Jacot’s resignation. Schaefer, who has been with Arcadia since 2020 and its president and CEO since 2022, brings a robust financial background to the role, including a past as a finance director in the food industry and an equity research analyst. His academic credentials include a BBA and an MBA from prestigious institutions, underscoring his expertise in economics and finance.
See more data about RKDA stock on TipRanks’ Stock Analysis page.